ImmunoCellular Therapeutics, Ltd. announced that on April 14, 2015, Richard Chin notified the Nominating and Corporate Governance Committee of the company that he will not stand for re-election as a director at the company's 2015 Annual Meeting of Stockholders. Dr. Chin will remain a director until the Annual Meeting and has no disagreements with the company relating to it's operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.199 USD | -5.24% | +32.67% | -14.22% |
1st Jan change | Capi. | |
---|---|---|
-14.22% | 23.79M | |
+33.63% | 50.85B | |
-0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+11.18% | 26.11B | |
-21.95% | 19.13B | |
+8.61% | 13.05B | |
+28.31% | 12.16B | |
+24.73% | 12.08B |
- Stock Market
- Equities
- IMUC Stock
- News EOM Pharmaceuticals Holdings, Inc.
- Richard Chin Not to Stand for Re-Election as Director of Immunocellular Therapeutics, Ltd